AxoGen Inc reports results for the quarter ended June 30 - Earnings Summary
AxoGen Inc reports results for the quarter ended June 30 - Earnings Summary
AxoGen Inc AXGN.OQ reported quarterly adjusted earnings of 12 cents per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of nine analysts for the quarter was for earnings of 12 cents per share. Wall Street expected results to range from 9 cents to 15 cents per share.
Revenue rose 23.1% to $69.73 million from a year ago; analysts expected $67.10 million.
AxoGen Inc's reported EPS for the quarter was a loss of 3 cents.
The company reported a quarterly loss of $1.52 million.
AxoGen Inc shares had fallen by 10.9% this quarter and gained 25.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for AxoGen Inc is $50.00, about 17.7% above its last closing price of $41.15
This summary was machine generated from LSEG data July 29 at 04:50 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.12 | 0.12 | Met |
Mar. 31 2026 | 0.07 | 0.07 | Met |
Dec. 31 2025 | 0.10 | 0.07 | Missed |
Sep. 30 2025 | 0.07 | 0.12 | Beat |